<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02512120</url>
  </required_header>
  <id_info>
    <org_study_id>Autoflow46</org_study_id>
    <nct_id>NCT02512120</nct_id>
  </id_info>
  <brief_title>Volume Controlled Ventilation vs Autoflow-volume Controlled Ventilation</brief_title>
  <acronym>VCVAFVCV</acronym>
  <official_title>Comparison of Volume Controlled Ventilation(VCV) vs Autoflow-volume Controlled Ventilation(Autoflow-VCV) During Robot-assisted Laparoscopic Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University Anam Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Volume controlled ventilation(VCV) is a most common used ventilation mode during general
      anesthesia. But VCV can cause high airway peak pressure when patient under steep
      Trendelenberg position with pneumoperitoneum. Autoflow-VCV can reduce airway peak pressure
      and improve dynamic compliance. We will compare parameters(arterial blood gas analysis,
      airway compliance, etc) when each group applied VCV and autoflow-VCV during RALP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Robot assisted laparoscopic radical prostatectomy(RALP) has been used to treatment of
      prostate cancer since 2001. RALP offers some advantage such as reduced blood loss, sparing
      nerves, less postoperative pain. However, RALP require steep Trendelenberg position with
      pneumoperitoneum. It can cause increased airway peak pressure and unwanted hemodynamic effect
      under conventional volume controlled ventilation(VCV). Autoflow-VCV use decelerating flow,
      can reduce airway peak pressure and improve dynamic compliance.

      We will compare parameters(arterial blood gas analysis, airway compliance, etc) when each
      group applied VCV and autoflow-VCV during RALP.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The backgroud of this study was not well discussed.
  </why_stopped>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Airway pressure</measure>
    <time_frame>4hours</time_frame>
    <description>Airway pressure will be measured under specified ventilation mode.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vital sign</measure>
    <time_frame>4hours</time_frame>
    <description>Vital sign will be measured under specified ventilation mode.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Arterial blood gas analysis</measure>
    <time_frame>4hours</time_frame>
    <description>Arterial blood gas analysis will be measured under specified ventilation mode.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>volume controlled ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized 23 patients will be applied VCV during RALP.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>autoflow-volume controlled ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomized 23 patients will be applied autoflow-VCV during RALP.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>volume controlled ventilation</intervention_name>
    <description>After induction of anesthesia and intubation, patients will be applied VCV by Zeus®(Dräger, Germany).
- Tidal volume : 8ml/kg(ieal body weight), inspiration:expiration ratio = 1:2, FiO2 = 0.5, fresh gas flow = 3L/min respiratory rate(RR) : 12/min. After position, RR can changed 2 times each per 5 minutes to maintain end tidal CO2 around 35. Positive end expiratory pressure will not used.</description>
    <arm_group_label>volume controlled ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>autoflow-volume controlled ventilation</intervention_name>
    <description>After induction of anesthesia and intubation, patients will be applied autoflow- VCV by Zeus®(Dräger, Germany).
- Tidal volume : 8ml/kg(ideal body weight), inspiration:expiration ratio = 1:2, FiO2 = 0.5, fresh gas flow = 3L/min respiratory rate(RR) : 12/min. After position, RR can changed 2 times each per 5 minutes to maintain end tidal CO2 around 35. Positive end expiratory pressure will not used.</description>
    <arm_group_label>autoflow-volume controlled ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (age 19-65)

          -  American Society of Anesthesiology Classification I-III

        Exclusion Criteria:

          -  cardiovascular disease, cerebrovascular disease, pulmonary disease

          -  over BMI 30
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hye-Won Shin, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of anesthesiology and pain medicine, Korea University Anam Hospital</affiliation>
  </overall_official>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2015</study_first_submitted>
  <study_first_submitted_qc>July 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2015</study_first_posted>
  <last_update_submitted>April 26, 2016</last_update_submitted>
  <last_update_submitted_qc>April 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University Anam Hospital</investigator_affiliation>
    <investigator_full_name>Hye-Won Shin</investigator_full_name>
    <investigator_title>Director, MD, PhD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

